OupeptideSemaglutide
Ordered Semaglutide from Oupeptide? Mail in a sample (US only) and let us test it for free.
Test my supplyOupeptide's Semaglutide profile is weakened by a late reversal after initially clean 2025 results. January tests showed a -55% fill and then an identity fail with 0 mg detected, with no batch IDs to help separate lots.
Corporate records point to a Guangzhou body-care/collagen business while the storefront presents a US/NY location string. The investigation maps cloned sister domains, shared WhatsApp agents, special-line shipping, and COA chain-of-custody gaps.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Oupeptide rows.
Cancel anytime
About Oupeptide test results from Finnrick
Oupeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 190 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Oupeptide peptides in this dataset are BPC-157 (10 tests), Cagrilintide (4 tests) and GHK-Cu (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 190 recent tests. It also includes 4 corrections related to this vendor.
Ordered Semaglutide from Oupeptide? Mail in a sample (US only) and let us test it for free.
Test my supply